A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection

Dexlansoprazole MR is the R-enantiomer of lansoprazole that is delivered by a dual delayed release formulation. It is effective for symptom control of patients with gastroesophageal reflux disease. However, its efficacy in the treatment of Helicobacter pylori infection remains unclear. This pilot, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Deng-Chyang, Kuo, Chao-Hung, Tsay, Feng-Woei, Hsu, Wen-Hung, Chen, Angela, Hsu, Ping-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839877/
https://www.ncbi.nlm.nih.gov/pubmed/26986096
http://dx.doi.org/10.1097/MD.0000000000002698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839877/
https://www.ncbi.nlm.nih.gov/pubmed/26986096
http://dx.doi.org/10.1097/MD.0000000000002698

Ejemplares similares